Clinical Trials Browser

OTHER × Breast Neoplasms × tetrathiomolybdate × Clear all

NCT00195091 2025-05-16

Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer

Phase 2 Terminated

16 enrolled 5 charts

Breast Neoplasms